These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 32810756)
21. Impaired associative taste learning and abnormal brain activation in kinase-defective eEF2K mice. Gildish I; Manor D; David O; Sharma V; Williams D; Agarwala U; Wang X; Kenney JW; Proud CG; Rosenblum K Learn Mem; 2012 Feb; 19(3):116-25. PubMed ID: 22366775 [TBL] [Abstract][Full Text] [Related]
22. Pharmacological eEF2K activation promotes cell death and inhibits cancer progression. De Gassart A; Demaria O; Panes R; Zaffalon L; Ryazanov AG; Gilliet M; Martinon F EMBO Rep; 2016 Oct; 17(10):1471-1484. PubMed ID: 27572820 [TBL] [Abstract][Full Text] [Related]
23. Elongation Factor 2 Kinase Is Regulated by Proline Hydroxylation and Protects Cells during Hypoxia. Moore CE; Mikolajek H; Regufe da Mota S; Wang X; Kenney JW; Werner JM; Proud CG Mol Cell Biol; 2015 May; 35(10):1788-804. PubMed ID: 25755286 [TBL] [Abstract][Full Text] [Related]
26. Eukaryotic elongation factor 2 kinase upregulates the expression of proteins implicated in cell migration and cancer cell metastasis. Xie J; Shen K; Lenchine RV; Gethings LA; Trim PJ; Snel MF; Zhou Y; Kenney JW; Kamei M; Kochetkova M; Wang X; Proud CG Int J Cancer; 2018 May; 142(9):1865-1877. PubMed ID: 29235102 [TBL] [Abstract][Full Text] [Related]
27. A decrease in eukaryotic elongation factor 2 phosphorylation is required for local translation of sensorin and long-term facilitation in Aplysia. McCamphill PK; Ferguson L; Sossin WS J Neurochem; 2017 Jul; 142(2):246-259. PubMed ID: 28345161 [TBL] [Abstract][Full Text] [Related]
28. [Eukaryotic elongation factor 2 kinase and cancer]. Wang GZ; Qi X; Li J Yao Xue Xue Bao; 2015 Jul; 50(7):808-13. PubMed ID: 26552140 [TBL] [Abstract][Full Text] [Related]
30. Calcium/Calmodulin-Dependent Protein Kinase II and Eukaryotic Elongation Factor 2 Kinase Pathways Mediate the Antidepressant Action of Ketamine. Adaikkan C; Taha E; Barrera I; David O; Rosenblum K Biol Psychiatry; 2018 Jul; 84(1):65-75. PubMed ID: 29395043 [TBL] [Abstract][Full Text] [Related]
31. Regulation of the Elongation Phase of Protein Synthesis Enhances Translation Accuracy and Modulates Lifespan. Xie J; de Souza Alves V; von der Haar T; O'Keefe L; Lenchine RV; Jensen KB; Liu R; Coldwell MJ; Wang X; Proud CG Curr Biol; 2019 Mar; 29(5):737-749.e5. PubMed ID: 30773367 [TBL] [Abstract][Full Text] [Related]
32. Coordination of changes in expression and phosphorylation of eukaryotic elongation factor 2 (eEF2) and eEF2 kinase in hypertrophied cardiomyocytes. Kameshima S; Okada M; Ikeda S; Watanabe Y; Yamawaki H Biochem Biophys Rep; 2016 Sep; 7():218-224. PubMed ID: 28955910 [TBL] [Abstract][Full Text] [Related]
33. Novel regulation of the eEF2K/eEF2 pathway: prospects of 'PQBP1 promotes translational elongation and regulates hippocampal mGluR-LTD by suppressing eEF2 phosphorylation'. Shen Y; Han J; Zhang ZC J Mol Cell Biol; 2021 Aug; 13(5):392-394. PubMed ID: 33734395 [No Abstract] [Full Text] [Related]
34. The eEF2 kinase-induced STAT3 inactivation inhibits lung cancer cell proliferation by phosphorylation of PKM2. Xiao M; Xie J; Wu Y; Wang G; Qi X; Liu Z; Wang Y; Wang X; Hoque A; Oakhill J; Proud CG; Li J Cell Commun Signal; 2020 Feb; 18(1):25. PubMed ID: 32054489 [TBL] [Abstract][Full Text] [Related]
35. Eukaryotic elongation factor 2 kinase confers tolerance to stress conditions in cancer cells. Zhu H; Yang X; Liu J; Zhou L; Zhang C; Xu L; Qin Q; Zhan L; Lu J; Cheng H; Sun X Cell Stress Chaperones; 2015 Mar; 20(2):217-20. PubMed ID: 25248493 [TBL] [Abstract][Full Text] [Related]
36. eEF2K/eEF2 Pathway Controls the Excitation/Inhibition Balance and Susceptibility to Epileptic Seizures. Heise C; Taha E; Murru L; Ponzoni L; Cattaneo A; Guarnieri FC; Montani C; Mossa A; Vezzoli E; Ippolito G; Zapata J; Barrera I; Ryazanov AG; Cook J; Poe M; Stephen MR; Kopanitsa M; Benfante R; Rusconi F; Braida D; Francolini M; Proud CG; Valtorta F; Passafaro M; Sala M; Bachi A; Verpelli C; Rosenblum K; Sala C Cereb Cortex; 2017 Mar; 27(3):2226-2248. PubMed ID: 27005990 [TBL] [Abstract][Full Text] [Related]
37. Elongation factor 2 kinase promotes cell survival by inhibiting protein synthesis without inducing autophagy. Moore CE; Wang X; Xie J; Pickford J; Barron J; Regufe da Mota S; Versele M; Proud CG Cell Signal; 2016 Apr; 28(4):284-93. PubMed ID: 26795954 [TBL] [Abstract][Full Text] [Related]
38. Eukaryotic elongation factor-2 kinase (eEF2K): a potential therapeutic target in cancer. Fu LL; Xie T; Zhang SY; Liu B Apoptosis; 2014 Oct; 19(10):1527-31. PubMed ID: 25023961 [TBL] [Abstract][Full Text] [Related]
39. 1-Benzyl-3-cetyl-2-methylimidazolium iodide (NH125) induces phosphorylation of eukaryotic elongation factor-2 (eEF2): a cautionary note on the anticancer mechanism of an eEF2 kinase inhibitor. Chen Z; Gopalakrishnan SM; Bui MH; Soni NB; Warrior U; Johnson EF; Donnelly JB; Glaser KB J Biol Chem; 2011 Dec; 286(51):43951-43958. PubMed ID: 22020937 [TBL] [Abstract][Full Text] [Related]
40. Reduction of eEF2 kinase alleviates the learning and memory impairment caused by acrylamide. Wang XL; Zhang RN; Pan YL; Li ZM; Li HQ; Lei YT; Zhao FF; Hao XX; Ma WW; Yu CP; Yao HW; Wang XY; Lv JJ; Wu YH; Wang SY Cell Biosci; 2024 Aug; 14(1):106. PubMed ID: 39180059 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]